Susquehanna International Group, LLP Gossamer Bio, Inc. Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2025

A detailed history of Susquehanna International Group, LLP transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 2,916,109 shares of GOSS stock, worth $3.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,916,109

Previous 577,874 404.63%

Holding current value

$3.06 Million

Previous $520,000 516.73%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$0.85 - $1.53 $1.99 Million - $3.58 Million	2,338,235 Added 404.63%	2,916,109 $3.21 Million
Q4 2024 Feb 14, 2025	BUY	$0.66 - $1.07 $149,762 - $242,796	226,913 Added 64.65%	577,874 $520,000
Q3 2024 Nov 14, 2024	BUY	$0.79 - $1.25 $13,719 - $21,708	17,367 Added 5.21%	350,961 $347,000
Q2 2024 Aug 15, 2024	SELL	$0.51 - $1.27 $754,193 - $1.88 Million	-1,478,811 Reduced 81.59%	333,594 $300,000
Q1 2024 May 07, 2024	BUY	$0.8 - $1.51 $1.05 Million - $1.98 Million	1,312,583 Added 262.61%	1,812,405 $2.14 Million
Q4 2023 Feb 14, 2024	SELL	$0.48 - $1.08 $30,950 - $69,639	-64,481 Reduced 11.43%	499,822 $454,000
Q3 2023 Nov 14, 2023	SELL	$0.78 - $1.82 $144,829 - $337,935	-185,679 Reduced 24.76%	564,303 $468,000
Q2 2023 Aug 11, 2023	SELL	$0.98 - $1.53 $1.18 Million - $1.85 Million	-1,208,072 Reduced 61.7%	749,982 $899,000
Q1 2023 May 16, 2023	BUY	$0.96 - $2.92 $1.62 Million - $4.93 Million	1,688,552 Added 626.55%	1,958,054 $2.47 Million
Q4 2022 Feb 14, 2023	BUY	$1.74 - $12.87 $306,321 - $2.27 Million	176,047 Added 188.38%	269,502 $584,000
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $673,810 - $1.39 Million	93,455 New	93,455 $1.12 Million
Q1 2022 May 16, 2022	SELL	$8.44 - $12.49 $180,565 - $267,211	-21,394 Reduced 29.12%	52,082 $452,000
Q4 2021 Feb 14, 2022	BUY	$10.12 - $14.07 $346,610 - $481,897	34,250 Added 87.31%	73,476 $831,000
Q3 2021 Nov 15, 2021	SELL	$7.25 - $13.23 $278,726 - $508,627	-38,445 Reduced 49.5%	39,226 $493,000
Q2 2021 Aug 11, 2021	BUY	$8.0 - $9.75 $84,048 - $102,433	10,506 Added 15.64%	77,671 $631,000
Q1 2021 May 17, 2021	SELL	$8.63 - $10.94 $541,178 - $686,036	-62,709 Reduced 48.28%	67,165 $621,000
Q4 2020 Feb 16, 2021	BUY	$8.3 - $13.59 $58,979 - $96,570	7,106 Added 5.79%	129,874 $1.26 Million
Q3 2020 Nov 16, 2020	BUY	$11.3 - $14.75 $301,032 - $392,940	26,640 Added 27.71%	122,768 $1.52 Million
Q1 2020 May 15, 2020	BUY	$8.0 - $15.48 $362,800 - $702,018	45,350 Added 89.31%	96,128 $976,000
Q3 2019 Nov 14, 2019	BUY	$16.02 - $22.47 $813,463 - $1.14 Million	50,778 New	50,778 $853,000

Others Institutions Holding GOSS

# of Institutions

122

Shares Held

160M

Call Options Held

2.11M

Put Options Held

57.8K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $98.7M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Gossamer Bio, Inc. Transaction History